Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice

Cheryl Y C So1, Patrick W L Leung, Se-Fong Hung

  • 1Kwai Chung Hospital, Hospital Authority, Hong Kong. cheryl-so@cuhk.edu.hk

Insights

Adding behavioral treatment (BT) to methylphenidate significantly improved ADHD symptoms in Chinese children more than medication alone. These benefits persisted, supporting BT

Area of Science:

  • Child and Adolescent Psychiatry
  • Behavioral Psychology
  • Clinical Pharmacology

Background:

  • Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder in children.
  • Investigating effective treatment strategies for ADHD in diverse populations is crucial.
  • Routine clinical practice settings require evidence-based interventions for ADHD management.

Purpose of the Study:

  • To compare the effectiveness of combined methylphenidate and behavioral treatment (BT) versus methylphenidate-only for Chinese children with ADHD.
  • To evaluate treatment outcomes in a real-world clinical setting in Hong Kong.
  • To assess the long-term effects of the combined treatment approach.

Main Methods:

  • A randomized group comparison design was employed over a 6-month period.
  • Two treatment conditions were compared: methylphenidate-only and methylphenidate/BT.
  • The Strengths and Weaknesses of ADHD Symptoms and Normal Behaviours (SWAN) Rating Scale was used for assessments at multiple time points, including follow-ups.

Main Results:

  • Combined methylphenidate/BT was more effective than methylphenidate-only in reducing ADHD and Oppositional Defiant Disorder (ODD) symptoms initially.
  • The benefits of the combined treatment were sustained at 6-month and 12-month follow-ups.
  • Parental attitudes toward medication improved in both groups, while attitudes toward BT remained positive.

Conclusions:

  • Behavioral treatment (BT) offers added benefits when combined with medication for Chinese children diagnosed with ADHD.
  • The findings support the integration of BT into routine clinical practice for ADHD management.
  • Healthcare professionals can effectively implement combined treatment strategies using standard medical and paramedical staff.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.